158 related articles for article (PubMed ID: 7656903)
1. Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines.
Scotto C; Keller JM; Schohn H; Dauça M
Eur J Cell Biol; 1995 Apr; 66(4):375-81. PubMed ID: 7656903
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of stimulation of peroxisomal beta-oxidation in rat heart by partially hydrogenated fish oil.
Kvannes J; Eikhom TS; Flatmark T
Biochim Biophys Acta; 1995 Mar; 1255(1):39-49. PubMed ID: 7893736
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
Rivero A; Monreal JI; Gil MJ
Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
[TBL] [Abstract][Full Text] [Related]
4. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
Périchon R; Bourre JM
Biochem Mol Biol Int; 1995 Oct; 37(3):475-80. PubMed ID: 8595387
[TBL] [Abstract][Full Text] [Related]
5. The peroxisomal beta-oxidation enzyme system of rat heart. Basal level and effect of the peroxisome proliferator clofibrate.
Kvannes J; Eikhom TS; Flatmark T
Biochim Biophys Acta; 1994 Nov; 1201(2):203-16. PubMed ID: 7947933
[TBL] [Abstract][Full Text] [Related]
6. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
Flatmark T; Christiansen EN; Kryvi H
Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
8. Clofibrate does not induce peroxisomal 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoyl coenzyme A oxidation in rat liver. Evidence that this reaction is catalyzed by an enzyme system different from that of peroxisomal acyl-coenzyme A oxidation.
Pedersen JI; Hvattum E; Flatabø T; Björkhem I
Biochem Int; 1988 Jul; 17(1):163-9. PubMed ID: 3190714
[TBL] [Abstract][Full Text] [Related]
9. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
Passilly P; Jannin B; Hassell SJ; Latruffe N
Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
[TBL] [Abstract][Full Text] [Related]
10. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting.
Beier K; Völkl A; Hashimoto T; Fahimi HD
Eur J Cell Biol; 1988 Aug; 46(3):383-93. PubMed ID: 2903052
[TBL] [Abstract][Full Text] [Related]
11. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
12. Effects of hepatic peroxisome proliferators and 12-O-tetradecanoyl phorbol-13-acetate on catalase and other enzyme activities of embryonic cells in vitro.
Mikalsen SO; Ruyter B; Sanner T
Biochem Pharmacol; 1990 Feb; 39(3):527-35. PubMed ID: 2306265
[TBL] [Abstract][Full Text] [Related]
13. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.
Pacot C; Petit M; Rollin M; Behechti N; Moisant M; Deslex P; Althoff J; Lhuguenot JC; Latruffe N
Arch Biochem Biophys; 1996 Mar; 327(1):181-8. PubMed ID: 8615689
[TBL] [Abstract][Full Text] [Related]
14. Localization of carnitine acyltransferases and acyl-CoA beta-oxidation enzymes in small intestinal microperoxisomes (peroxisomes) of normal and clofibrate treated mice.
Small GM; Burdett K; Connock MJ
Biochem Int; 1983 Aug; 7(2):263-72. PubMed ID: 6679343
[TBL] [Abstract][Full Text] [Related]
15. Liver peroxisomes in newborns from clofibrate-treated rats. II. A biochemical study of the recovery period.
Sartori C; Stefanini S; Cimini A; Di Giulio A; Cerù MP
Biol Cell; 1992; 74(3):315-24. PubMed ID: 1628114
[TBL] [Abstract][Full Text] [Related]
16. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
Staels B; Vu-Dac N; Kosykh VA; Saladin R; Fruchart JC; Dallongeville J; Auwerx J
J Clin Invest; 1995 Feb; 95(2):705-12. PubMed ID: 7860752
[TBL] [Abstract][Full Text] [Related]
17. Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy.
Fournier B; Saudubray JM; Benichou B; Lyonnet S; Munnich A; Clevers H; Poll-The BT
J Clin Invest; 1994 Aug; 94(2):526-31. PubMed ID: 8040306
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal beta-oxidation in primary cultures of rainbow trout hepatocytes.
Donohue M; Baldwin LA; Leonard DA; Kostecki PT; Calabrese EJ
Ecotoxicol Environ Saf; 1993 Oct; 26(2):127-32. PubMed ID: 7504609
[TBL] [Abstract][Full Text] [Related]
19. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid beta-oxidation system.
Aoyama T; Souri M; Kamijo T; Ushikubo S; Hashimoto T
Biochem Biophys Res Commun; 1994 Jun; 201(3):1541-7. PubMed ID: 8024599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
